Goodpasture Syndrome Treatment Market, Global Outlook and Forecast 2022-2028

July 2024 | 69 pages | ID: GFFE1EEFADB3EN
Market Monitor Global

Abstracts

Goodpasture syndrome may be caused by viral infection and / or inhalation of certain chemical substances causing primary lung damage.

This report contains market size and forecasts of Goodpasture Syndrome Treatment in Global, including the following market information:

Global Goodpasture Syndrome Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Goodpasture Syndrome Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Goodpasture Syndrome Treatment include Amneal Pharmaceuticals, Bristol-Myers Squibb, Sandoz, Fibrostatin, Hansa Medical and Acer Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Goodpasture Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Goodpasture Syndrome Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Goodpasture Syndrome Treatment Market Segment Percentages, by Type, 2021 (%)

• Corticosteroids
• Immunosuppressive Drugs
• Others

Global Goodpasture Syndrome Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Goodpasture Syndrome Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Others

Global Goodpasture Syndrome Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Goodpasture Syndrome Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Goodpasture Syndrome Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Goodpasture Syndrome Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amneal Pharmaceuticals
• Bristol-Myers Squibb
• Sandoz
• Fibrostatin
• Hansa Medical
• Acer Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Goodpasture Syndrome Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Goodpasture Syndrome Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GOODPASTURE SYNDROME TREATMENT OVERALL MARKET SIZE

2.1 Global Goodpasture Syndrome Treatment Market Size: 2021 VS 2028
2.2 Global Goodpasture Syndrome Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Goodpasture Syndrome Treatment Players in Global Market
3.2 Top Global Goodpasture Syndrome Treatment Companies Ranked by Revenue
3.3 Global Goodpasture Syndrome Treatment Revenue by Companies
3.4 Top 3 and Top 5 Goodpasture Syndrome Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Goodpasture Syndrome Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Goodpasture Syndrome Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Goodpasture Syndrome Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Goodpasture Syndrome Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Goodpasture Syndrome Treatment Market Size Markets, 2021 & 2028
  4.1.2 Corticosteroids
  4.1.3 Immunosuppressive Drugs
  4.1.4 Others
4.2 By Type - Global Goodpasture Syndrome Treatment Revenue & Forecasts
  4.2.1 By Type - Global Goodpasture Syndrome Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Goodpasture Syndrome Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Goodpasture Syndrome Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Goodpasture Syndrome Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Goodpasture Syndrome Treatment Revenue & Forecasts
  5.2.1 By Application - Global Goodpasture Syndrome Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Goodpasture Syndrome Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Goodpasture Syndrome Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Goodpasture Syndrome Treatment Market Size, 2021 & 2028
6.2 By Region - Global Goodpasture Syndrome Treatment Revenue & Forecasts
  6.2.1 By Region - Global Goodpasture Syndrome Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Goodpasture Syndrome Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Goodpasture Syndrome Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Goodpasture Syndrome Treatment Revenue, 2017-2028
  6.3.2 US Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.3.3 Canada Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.3.4 Mexico Goodpasture Syndrome Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Goodpasture Syndrome Treatment Revenue, 2017-2028
  6.4.2 Germany Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.4.3 France Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.4.4 U.K. Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.4.5 Italy Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.4.6 Russia Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.4.8 Benelux Goodpasture Syndrome Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Goodpasture Syndrome Treatment Revenue, 2017-2028
  6.5.2 China Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.5.3 Japan Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.5.4 South Korea Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.5.6 India Goodpasture Syndrome Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Goodpasture Syndrome Treatment Revenue, 2017-2028
  6.6.2 Brazil Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.6.3 Argentina Goodpasture Syndrome Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Goodpasture Syndrome Treatment Revenue, 2017-2028
  6.7.2 Turkey Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.7.3 Israel Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Goodpasture Syndrome Treatment Market Size, 2017-2028
  6.7.5 UAE Goodpasture Syndrome Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Amneal Pharmaceuticals
  7.1.1 Amneal Pharmaceuticals Corporate Summary
  7.1.2 Amneal Pharmaceuticals Business Overview
  7.1.3 Amneal Pharmaceuticals Goodpasture Syndrome Treatment Major Product Offerings
  7.1.4 Amneal Pharmaceuticals Goodpasture Syndrome Treatment Revenue in Global Market (2017-2022)
  7.1.5 Amneal Pharmaceuticals Key News
7.2 Bristol-Myers Squibb
  7.2.1 Bristol-Myers Squibb Corporate Summary
  7.2.2 Bristol-Myers Squibb Business Overview
  7.2.3 Bristol-Myers Squibb Goodpasture Syndrome Treatment Major Product Offerings
  7.2.4 Bristol-Myers Squibb Goodpasture Syndrome Treatment Revenue in Global Market (2017-2022)
  7.2.5 Bristol-Myers Squibb Key News
7.3 Sandoz
  7.3.1 Sandoz Corporate Summary
  7.3.2 Sandoz Business Overview
  7.3.3 Sandoz Goodpasture Syndrome Treatment Major Product Offerings
  7.3.4 Sandoz Goodpasture Syndrome Treatment Revenue in Global Market (2017-2022)
  7.3.5 Sandoz Key News
7.4 Fibrostatin
  7.4.1 Fibrostatin Corporate Summary
  7.4.2 Fibrostatin Business Overview
  7.4.3 Fibrostatin Goodpasture Syndrome Treatment Major Product Offerings
  7.4.4 Fibrostatin Goodpasture Syndrome Treatment Revenue in Global Market (2017-2022)
  7.4.5 Fibrostatin Key News
7.5 Hansa Medical
  7.5.1 Hansa Medical Corporate Summary
  7.5.2 Hansa Medical Business Overview
  7.5.3 Hansa Medical Goodpasture Syndrome Treatment Major Product Offerings
  7.5.4 Hansa Medical Goodpasture Syndrome Treatment Revenue in Global Market (2017-2022)
  7.5.5 Hansa Medical Key News
7.6 Acer Therapeutics
  7.6.1 Acer Therapeutics Corporate Summary
  7.6.2 Acer Therapeutics Business Overview
  7.6.3 Acer Therapeutics Goodpasture Syndrome Treatment Major Product Offerings
  7.6.4 Acer Therapeutics Goodpasture Syndrome Treatment Revenue in Global Market (2017-2022)
  7.6.5 Acer Therapeutics Key News

8 CONCLUSION


9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Goodpasture Syndrome Treatment Market Opportunities & Trends in Global Market
Table 2. Goodpasture Syndrome Treatment Market Drivers in Global Market
Table 3. Goodpasture Syndrome Treatment Market Restraints in Global Market
Table 4. Key Players of Goodpasture Syndrome Treatment in Global Market
Table 5. Top Goodpasture Syndrome Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Goodpasture Syndrome Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Goodpasture Syndrome Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Goodpasture Syndrome Treatment Product Type
Table 9. List of Global Tier 1 Goodpasture Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Goodpasture Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Goodpasture Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Goodpasture Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Goodpasture Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Goodpasture Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Goodpasture Syndrome Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Goodpasture Syndrome Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Amneal Pharmaceuticals Corporate Summary
Table 31. Amneal Pharmaceuticals Goodpasture Syndrome Treatment Product Offerings
Table 32. Amneal Pharmaceuticals Goodpasture Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Goodpasture Syndrome Treatment Product Offerings
Table 35. Bristol-Myers Squibb Goodpasture Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Sandoz Corporate Summary
Table 37. Sandoz Goodpasture Syndrome Treatment Product Offerings
Table 38. Sandoz Goodpasture Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Fibrostatin Corporate Summary
Table 40. Fibrostatin Goodpasture Syndrome Treatment Product Offerings
Table 41. Fibrostatin Goodpasture Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Hansa Medical Corporate Summary
Table 43. Hansa Medical Goodpasture Syndrome Treatment Product Offerings
Table 44. Hansa Medical Goodpasture Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Acer Therapeutics Corporate Summary
Table 46. Acer Therapeutics Goodpasture Syndrome Treatment Product Offerings
Table 47. Acer Therapeutics Goodpasture Syndrome Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Goodpasture Syndrome Treatment Segment by Type in 2021
Figure 2. Goodpasture Syndrome Treatment Segment by Application in 2021
Figure 3. Global Goodpasture Syndrome Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Goodpasture Syndrome Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Goodpasture Syndrome Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Goodpasture Syndrome Treatment Revenue in 2021
Figure 8. By Type - Global Goodpasture Syndrome Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Goodpasture Syndrome Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Goodpasture Syndrome Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Goodpasture Syndrome Treatment Revenue Market Share, 2017-2028
Figure 12. US Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Goodpasture Syndrome Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Goodpasture Syndrome Treatment Revenue Market Share, 2017-2028
Figure 24. China Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Goodpasture Syndrome Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Goodpasture Syndrome Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Goodpasture Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Amneal Pharmaceuticals Goodpasture Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Goodpasture Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sandoz Goodpasture Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Fibrostatin Goodpasture Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Hansa Medical Goodpasture Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Acer Therapeutics Goodpasture Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)